EMLA Topical Cream

Lidocaine 2.5% / Prilocaine 2.5% topical anesthetic

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for EMLA Topical Cream, covering 2012-10-10 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers [Phase 2]

See pricing